ImmunityBio (IBRX) Stock Forecast, Price Target & Predictions
IBRX Stock Forecast
ImmunityBio stock forecast is as follows: an average price target of $8.00 (represents a 58.73% upside from IBRX’s last price of $5.04) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
IBRX Price Target
IBRX Analyst Ratings
Buy
ImmunityBio Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Aug 03, 2022 | Kelly Shi | Jefferies | $8.00 | $4.13 | 93.94% | 58.73% |
10
ImmunityBio Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | - |
Avg Price Target | - | - | - |
Last Closing Price | $5.04 | $5.04 | $5.04 |
Upside/Downside | -100.00% | -100.00% | -100.00% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 23, 2024 | EF Hutton | - | Buy | Initialise |
Apr 26, 2022 | Zacks Investment Research | - | Sell | Downgrade |
10
ImmunityBio Financial Forecast
ImmunityBio Revenue Forecast
Quarter
Dec 28 | Sep 28 | Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $139.00K | $360.00K | $73.00K | $118.00K | $35.00K | $14.00K | $390.00K | $66.00K | $339.00K | $139.00K |
Avg Forecast | $973.40M | $935.97M | $935.97M | $898.53M | $387.24M | $372.35M | $372.35M | $357.46M | $122.94M | $118.22M | $118.22M | $113.49M | $43.45M | $40.10M | $36.35M | $30.49M | $5.85M | $2.92M | $14.71M | $62.50K | $25.00K | $25.00K | $25.00K | $118.00K | $25.00K | $25.00K | $25.00K | $25.00K | $25.00K | $25.00K |
High Forecast | $978.96M | $941.30M | $941.30M | $903.65M | $389.45M | $374.47M | $374.47M | $359.49M | $123.65M | $118.89M | $118.89M | $114.13M | $43.70M | $40.32M | $36.55M | $30.67M | $6.07M | $2.94M | $14.80M | $62.86K | $25.14K | $25.14K | $25.14K | $118.00K | $25.00K | $25.00K | $25.00K | $25.00K | $25.00K | $25.00K |
Low Forecast | $967.68M | $930.47M | $930.47M | $893.25M | $384.97M | $370.16M | $370.16M | $355.36M | $122.22M | $117.52M | $117.52M | $112.82M | $43.19M | $39.86M | $36.13M | $30.31M | $5.62M | $2.91M | $14.63M | $62.13K | $24.85K | $24.85K | $24.85K | $118.00K | $25.00K | $25.00K | $25.00K | $25.00K | $25.00K | $25.00K |
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.56% | 14.40% | 2.92% | 1.00% | 1.40% | 0.56% | 15.60% | 2.64% | 13.56% | 5.56% |
Forecast
ImmunityBio EBITDA Forecast
Quarter
Dec 28 | Sep 28 | Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-79.94M | $-109.79M | $-82.93M | $-90.51M | $-78.70M | $-91.84M | $-83.17M | $-80.33M | $-80.72M | $-73.47M |
Avg Forecast | $-973.40M | $-935.97M | $-935.97M | $-898.53M | $-387.24M | $-372.35M | $-372.35M | $-357.46M | $-122.94M | $-118.22M | $-118.22M | $-113.49M | $-43.45M | $-40.10M | $-36.35M | $-30.49M | $-5.85M | $-2.92M | $-14.71M | $-62.50K | $-25.00K | $-25.00K | $-25.00K | $-118.00K | $-25.00K | $-73.84M | $-25.00K | $-25.00K | $-25.00K | $-98.38M |
High Forecast | $-967.68M | $-930.47M | $-930.47M | $-893.25M | $-384.97M | $-370.16M | $-370.16M | $-355.36M | $-122.22M | $-117.52M | $-117.52M | $-112.82M | $-43.19M | $-39.86M | $-36.13M | $-30.31M | $-5.62M | $-2.91M | $-14.63M | $-62.13K | $-24.85K | $-24.85K | $-24.85K | $-118.00K | $-25.00K | $-59.07M | $-25.00K | $-25.00K | $-25.00K | $-78.70M |
Low Forecast | $-978.96M | $-941.30M | $-941.30M | $-903.65M | $-389.45M | $-374.47M | $-374.47M | $-359.49M | $-123.65M | $-118.89M | $-118.89M | $-114.13M | $-43.70M | $-40.32M | $-36.55M | $-30.67M | $-6.07M | $-2.94M | $-14.80M | $-62.86K | $-25.14K | $-25.14K | $-25.14K | $-118.00K | $-25.00K | $-88.60M | $-25.00K | $-25.00K | $-25.00K | $-118.05M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3197.56% | 4391.56% | 3317.12% | 767.04% | 3148.12% | 1.24% | 3326.92% | 3213.12% | 3229.00% | 0.75% |
Forecast
ImmunityBio Net Income Forecast
Quarter
Dec 28 | Sep 28 | Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-233.39M | $-151.16M | $-108.33M | $-110.94M | $-94.59M | $-102.83M | $-91.55M | $-87.63M | $-89.39M | $-80.48M |
Avg Forecast | $417.38M | $405.72M | $410.26M | $372.43M | $125.07M | $123.96M | $128.63M | $118.44M | $-31.97M | $-25.75M | $-19.68M | $-25.68M | $-86.37M | $-85.78M | $-86.20M | $-92.31M | $-116.79M | $-124.26M | $-111.67M | $-136.10M | $-125.63M | $-188.45M | $-153.55M | $-192.34M | $-164.87M | $-84.13M | $-144.26M | $-137.39M | $-82.43M | $-106.61M |
High Forecast | $420.47M | $408.73M | $413.30M | $375.20M | $126.00M | $124.88M | $129.59M | $119.32M | $-31.72M | $-25.56M | $-19.53M | $-25.49M | $-85.71M | $-85.12M | $-85.54M | $-91.60M | $-115.90M | $-123.31M | $-110.82M | $-135.06M | $-124.68M | $-187.01M | $-152.38M | $-192.34M | $-164.87M | $-67.30M | $-144.26M | $-137.39M | $-82.43M | $-85.28M |
Low Forecast | $414.19M | $402.63M | $407.13M | $369.58M | $124.12M | $123.01M | $127.65M | $117.54M | $-32.20M | $-25.95M | $-19.83M | $-25.88M | $-87.01M | $-86.41M | $-86.84M | $-92.99M | $-117.66M | $-125.18M | $-112.50M | $-137.11M | $-126.56M | $-189.85M | $-154.69M | $-192.34M | $-164.87M | $-100.96M | $-144.26M | $-137.39M | $-82.43M | $-127.93M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.86% | 0.80% | 0.71% | 0.58% | 0.57% | 1.22% | 0.63% | 0.64% | 1.08% | 0.75% |
Forecast
ImmunityBio SG&A Forecast
Quarter
Dec 28 | Sep 28 | Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $29.05M | $32.68M | $26.21M | $19.31M | $16.57M | $40.61M | $27.91M | $29.63M | $32.45M | $45.27M |
Avg Forecast | $179.13B | $172.24B | $172.24B | $165.35B | $71.26B | $68.52B | $68.52B | $65.78B | $22.62B | $21.75B | $21.75B | $20.88B | $8.00B | $7.38B | $6.69B | $5.61B | $1.08B | $538.28M | $2.71B | $11.50M | $4.60M | $4.60M | $4.60M | $21.72M | $4.60M | $4.60M | $4.60M | $4.60M | $4.60M | $4.60M |
High Forecast | $180.15B | $173.23B | $173.23B | $166.30B | $71.67B | $68.91B | $68.91B | $66.16B | $22.75B | $21.88B | $21.88B | $21.00B | $8.04B | $7.42B | $6.73B | $5.64B | $1.12B | $541.35M | $2.72B | $11.57M | $4.63M | $4.63M | $4.63M | $21.72M | $4.60M | $4.60M | $4.60M | $4.60M | $4.60M | $4.60M |
Low Forecast | $178.08B | $171.23B | $171.23B | $164.38B | $70.84B | $68.12B | $68.12B | $65.40B | $22.49B | $21.63B | $21.63B | $20.76B | $7.95B | $7.34B | $6.65B | $5.58B | $1.03B | $535.12M | $2.69B | $11.43M | $4.57M | $4.57M | $4.57M | $21.72M | $4.60M | $4.60M | $4.60M | $4.60M | $4.60M | $4.60M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.31% | 7.10% | 5.70% | 0.89% | 3.60% | 8.83% | 6.07% | 6.44% | 7.05% | 9.84% |
Forecast
ImmunityBio EPS Forecast
Quarter
Dec 28 | Sep 28 | Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.35 | $-0.35 | $-0.27 | $-0.28 | $-0.24 | $-0.26 | $-0.23 | $-0.22 | $-0.23 | $-0.21 |
Avg Forecast | $0.60 | $0.58 | $0.59 | $0.53 | $0.18 | $0.18 | $0.18 | $0.17 | $-0.05 | $-0.04 | $-0.03 | $-0.04 | $-0.12 | $-0.12 | $-0.12 | $-0.13 | $-0.17 | $-0.18 | $-0.16 | $-0.20 | $-0.18 | $-0.27 | $-0.22 | $-0.28 | $-0.24 | $-0.22 | $-0.21 | $-0.20 | $-0.12 | $-0.41 |
High Forecast | $0.60 | $0.59 | $0.59 | $0.54 | $0.18 | $0.18 | $0.19 | $0.17 | $-0.05 | $-0.04 | $-0.03 | $-0.04 | $-0.12 | $-0.12 | $-0.12 | $-0.13 | $-0.17 | $-0.18 | $-0.16 | $-0.19 | $-0.18 | $-0.27 | $-0.22 | $-0.28 | $-0.24 | $-0.22 | $-0.21 | $-0.20 | $-0.12 | $-0.41 |
Low Forecast | $0.59 | $0.58 | $0.58 | $0.53 | $0.18 | $0.18 | $0.18 | $0.17 | $-0.05 | $-0.04 | $-0.03 | $-0.04 | $-0.12 | $-0.12 | $-0.12 | $-0.13 | $-0.17 | $-0.18 | $-0.16 | $-0.20 | $-0.18 | $-0.27 | $-0.22 | $-0.28 | $-0.24 | $-0.22 | $-0.21 | $-0.20 | $-0.12 | $-0.41 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.94% | 1.30% | 1.23% | 1.00% | 1.00% | 1.18% | 1.10% | 1.10% | 1.92% | 0.51% |
Forecast
ImmunityBio Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
ELEV | Elevation Oncology | $0.61 | $9.00 | 1375.41% | Buy |
CVAC | CureVac | $2.56 | $29.00 | 1032.81% | Buy |
XFOR | X4 Pharmaceuticals | $0.37 | $3.67 | 891.89% | Buy |
LXRX | Lexicon Pharmaceuticals | $0.77 | $6.00 | 679.22% | Buy |
LIFE | aTyr Pharma | $1.90 | $11.00 | 478.95% | Buy |
PDSB | PDS Bio | $2.20 | $9.00 | 309.09% | Buy |
VIR | Vir Bio | $6.95 | $26.60 | 282.73% | Buy |
VKTX | Viking Therapeutics | $51.63 | $102.40 | 98.33% | Buy |
MCRB | Seres Therapeutics | $0.73 | $1.25 | 71.23% | Buy |
ARDX | Ardelyx | $5.12 | $8.75 | 70.90% | Buy |
IBRX | ImmunityBio | $5.04 | $8.00 | 58.73% | Buy |
KRYS | Krystal Biotech | $182.29 | $191.00 | 4.78% | Buy |
EFTR | eFFECTOR Therapeutics | - | $5.50 | - | Buy |
MDGL | Madrigal Pharmaceuticals | $329.24 | $315.75 | -4.10% | Buy |
TGTX | TG Therapeutics | $34.55 | $27.60 | -20.12% | Buy |